Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
Go back to Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 17.92 -0.05 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.97 | 52 Week High | $0.19 | |||
| Open | $18.08 | 52 Week Low | $0.07 | |||
| Day High | $18.19 | P/E | N/A | |||
| Day Low | $17.83 | EPS | $-0.01 | |||
| Volume | 1,156,493 | |||||
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 17.92 -0.05 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.97 | 52 Week High | $0.19 | |||
| Open | $18.08 | 52 Week Low | $0.07 | |||
| Day High | $18.19 | P/E | N/A | |||
| Day Low | $17.83 | EPS | $-0.01 | |||
| Volume | 1,156,493 | |||||
